Vergo Pharma Research Private Limited

Vergo Pharma Research Private Limited - pharma in Tiswadi, Goa, India. Directors, charges & compliance details.
CIN U73100GA2010PTC014001 Incorporated 23 September 2010 ROC Goa HQ Tiswadi, Goa, India
Merged Private Limited Company pharma
Data last updated
Revenue · FY 2024
₹34.4 Cr
▼ 1% YoY
Net profit · FY 2024
₹3.64 Cr
Net margin 10.6%
EBITDA · FY 2024
₹6.6 Cr
EBITDA margin 19.2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹2.9 Cr
Secured borrowings
Company age
16 yrs
Est. 2010
Employees · EPFO
147
Provident fund records

About Vergo Pharma Research Private Limited

Data last updated:

Vergo Pharma Research Private Limited was a private limited company based in Tiswadi, Goa, India, operated as a subsidiary of Vergo Pharma Research Laboratories Private Limited. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 23 September 2010.

The company was registered with the Registrar of Companies (ROC), Goa, under CIN U73100GA2010PTC014001. Its GSTIN is 30AADCV5455E1ZM (Goa).

The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors including Prasad Vassudev Keni (Managing Director) and Kashyap Prasad Keni.

Its last annual general meeting (AGM) was held on 20 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office was at 24/1 D – 1 Corlim Industrial Estate Corlim, Tiswadi, Goa, India – 403110.

As per the financials filed for FY 2024, the company reported a revenue of ₹34.4 Cr, a decline of 1% compared to the previous year. For the same year it recorded a net profit of ₹3.64 Cr (net margin 10.6%) and EBITDA of ₹6.6 Cr (EBITDA margin 19.2%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years and 23% over five years.

The company had about 147 employees on its provident fund (EPFO) records before it was dissolved.

The company was associated with 1 brand: VerGo Clinicals. As per MCA filings, the company had open charges of ₹2.9 Cr on record. Court records list 1 case involving the company, including 1 filed against it.

The last known website on record is vergolabs.com.

Company details

CIN U73100GA2010PTC014001
Registration Number 014001
Incorporation Date 23 September 2010
ROC Goa
Listing Status Unlisted
Company Status Amalgamated
Date of Last AGM 20 September 2024
Date of Balance Sheet 31 March 2024
Parent Company Vergo Pharma Research Laboratories Private Limited
Compliance Status Active Compliant

CIN history

Vergo Pharma Research has one previous CIN (Corporate Identification Number): U73100MH2010PTC208075. The current CIN is U73100GA2010PTC014001, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U73100GA2010PTC014001Current
U73100MH2010PTC208075Previous

Contact details

Vergo Pharma Research Private Limited's registered office is in Tiswadi, Goa. Its website is vergolabs.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    24/1 D – 1 Corlim Industrial Estate Corlim, Tiswadi, Goa, India – 403110
  • Industry
    Pharma, Pharma Contract R&D

To see the full contact details of Vergo Pharma Research Private Limited, buy the company report.

Comprehensive company report
Vergo Pharma Research Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Vergo Pharma Research operates one associated brand: VerGo Clinicals. Each brand links to its own profile.

BrandDescriptionWebsite
Offers clinical research, bioanalytical, and data management services as a Contract Research Organization (CRO).vergoclinicals.com

Business activity

The main business activity of Vergo Pharma Research is professional, scientific and technical. In detail, this covers scientific research and development.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
MProfessional, Scientific and TechnicalM5Scientific research and development

To see the full business activity and turnover split of Vergo Pharma Research Private Limited, buy the company report.

Financials of Vergo Pharma Research Private Limited

FY 2024 filings available

Vergo Pharma Research Private Limited reported revenue of ₹34.4 Cr (down 1% YoY) for FY 2024.

Revenue · FY 2024
₹34.4 Cr ▼ 1%
Net profit · FY 2024
₹3.64 Cr margin 10.6%
EBITDA · FY 2024
₹6.6 Cr margin 19.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 1%
3 years · compounded
▲ 15%
5 years · compounded
▲ 23%
EBITDA CAGR growth
1 year
▼ 37%
3 years · compounded
▲ 6%
5 years · compounded
▲ 70%

Revenue fell 1% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 23%. EBITDA fell 37% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹34.4 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹6.6 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹3.64 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin19.2%
Net Profit Margin10.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Vergo Pharma Research Private Limited, buy the company report.

Board of directors of Vergo Pharma Research Private Limited

Vergo Pharma Research has 4 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.

Directors (as last reported)
NameDesignationAppointment DateTenureStatus
Kashyap Prasad KeniDirector19 Sep 20197 Years 1 MonthsAs last reported
Vini Prasad KeniDirector23 Sep 201016 Years 1 MonthsAs last reported
Prasad Vassudev KeniManaging Director23 Sep 201016 Years 1 MonthsAs last reported
Praveen KhullarDirector23 Jul 20242 Years 3 MonthsAs last reported

Peer comparison

Vergo Pharma Research Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Synergen Bio Private Limited₹36.01 Cr (FY 2024)-25.0%Pune, Maharashtra, India
Vergo Pharma Research Private Limitedthis company₹34.4 Cr (FY 2024)₹3.64 Cr10.6%-1.0%147Tiswadi, Goa, India
Perrigo Laboratories India Private Limited₹33.99 Cr (FY 2022)-14.0%Thane, Maharashtra, India
Intonation Research Laboratories Private Limited₹33.31 Cr (FY 2025)14.0%Hyderabad, Telangana, India

To see the full peer comparison of Vergo Pharma Research Private Limited, buy the company report.

Auditor

Vergo Pharma Research Private Limited is audited by Ashish V Prabhu Verlekar & Co for the financial year 2024.

Auditor firmFinancial yearFirm registration number
Ashish V Prabhu Verlekar & CoFY 2024117774W

Shareholding

The shareholding of Vergo Pharma Research Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Vergo Pharma Research Private Limited, buy the company report.

Charges & borrowings

Open charges
₹2.9 Cr
Satisfied charges
None
Breakdown by lending institutions
Tata Capital Financial Services Limited₹2.90 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
29 Nov 2022100651117Tata Capital Financial Services Limited₹2.9 CrOpen

Total charge records: 1 View all charges

MSME payment delays

Vergo Pharma Research Private Limited has 10 MSME Form 1 returns on record between 2020 and 2024, listing 616 overdue payments to 62 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 62)

SupplierAmount dueDue sinceReported on
an individual supplier
Bharat Chemicals
an individual supplier
an individual supplier
an individual supplier

To see the full MSME payment records of Vergo Pharma Research Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Vergo Pharma Research Private Limited has a workforce of 147 employees on its EPFO records as of Apr 02, 2025, across 1 active EPFO establishment.

Employee count
147
Active EPFO establishments
1
Employee growth
15.75%

GST

Vergo Pharma Research has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
30AADCV5455E1ZMGoaActive01 Jul 2017

To see the full GST registrations and return filing status of Vergo Pharma Research Private Limited, buy the company report.

Recent activity

Vergo Pharma Research Private Limited has 10 board changes on record since 2010: 4 appointments and 6 cessations. The latest: Praveen Khullar ceased to be Additional Director on 19 Sep 2024.

AGM
Vergo Pharma Research Private Limited last Annual general meeting of members was held on 20 Sep 2024 as per latest MCA records.
Ceased
Praveen Khullar ceased to be Additional Director.
Appointed
Praveen Khullar was appointed as Director.
Filing
Vergo Pharma Research Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Goa.
Charges
A charge with Tata Capital Financial Services Limited amounted to Rs. 290.00 Lakh with Charge ID 100651117 was registered on 29 Nov 2022.
Ceased
Amol Shivaji Borkar ceased to be Additional Director.
Ceased
Kashyap Prasad Keni ceased to be Additional Director.
Appointed
Kashyap Prasad Keni was appointed as Director.
Ceased
Gajanan Jaivant Surlakar ceased to be Director.
Ceased
Sulba Venctexa Surlacar ceased to be Director.
Ceased
Prasad Vassudev Keni ceased to be Director.
Appointed
Prasad Vassudev Keni was appointed as Managing Director.

2 earlier events are in the company report.

Frequently asked questions

Vergo Pharma Research has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.

Vergo Pharma Research was a private limited company based in Tiswadi, Goa, India. The company worked in pharma contract r and d, within the pharma industry. It was incorporated on 23 September 2010 and is registered under CIN U73100GA2010PTC014001. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.

Vergo Pharma Research was incorporated on 23 September 2010. It is registered with the Registrar of Companies, Goa.

Vergo Pharma Research had 4 directors:

The CIN (Corporate Identification Number) of Vergo Pharma Research is U73100GA2010PTC014001. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

The registered office of Vergo Pharma Research is at 241 D – 1 Corlim Industrial Estate Corlim, Tiswadi, Goa, India – 403110.

Vergo Pharma Research can be reached through the website vergolabs.com. Its registered office is in Tiswadi, Goa, India.

The latest financial statements of Vergo Pharma Research on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 20 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Vergo Pharma Research is 30AADCV5455E1ZM, registered in Goa.

Vergo Pharma Research operated in the pharma industry, in the pharma contract r and d segment.

The peers of Vergo Pharma Research by revenue are Synergen Bio Private Limited, Perrigo Laboratories India Private Limited, Intonation Research Laboratories Private Limited, all in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development).

Vergo Pharma Research has 10 MSME Form 1 returns on record between 2020 and 2024, listing 616 overdue payments to 62 micro and small suppliers. The latest return was filed on 01 May 2024.